Mgr. Bc. Petra Májková

Analyst, Institute of Biostatistics and Analyses

correspondence Address:
Kamenice 753/5, 625 00 Brno

e‑mail:

Basic information

Type

Total number of publications: 20

2023

Clinical characteristics and mortality in all Czech patients after pacemaker implantation in the last decade

TABORSKY Milos SKALA Tomas DUŠEK Ladislav KAUTZNER Josef AIGLOVA Renata FEDORCO Marian JARKOVSKÝ Jiří BENEŠOVÁ Klára MÁJKOVÁ Petra

Article in Periodical

Frontiers in Cardiovascular Medicine, year: 2023, volume: 10, edition: December 2023, DOI

2020

Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors (TKI) treatment - prospective data from the Czech TULUNG registry

SKŘIČKOVÁ Jana MÁJKOVÁ Petra BAŘINOVÁ Magda BRATOVÁ Monika PEŠEK Miloš SVATOŇ Martin KOLEK Vítězslav FIŠER Ondřej KOUBKOVÁ Leona BENEJOVÁ Andrea VENCLÍČEK Ondřej ČERNOVSKÁ Markéta HAVEL Libor HRNČIARIK Michal ROUBEC Jaromír ZEMANOVÁ Milada OPÁLKA Petr KREJČÍ Jana KREJČÍ Dan ČOUPKOVÁ Helena MERTA Zdeněk

Conference abstract

Year: 2020, type: Conference abstract

2019

Charakteristika pacientů s NSCLC léčených inhibitory tyrozinkiázy (TKI) první a druhé generace po stanovení diagnózy v ČR

SKŘIČKOVÁ Jana MÁJKOVÁ Petra BAŘINOVÁ Magda PEŠEK Miloš KOLEK Vítězslav GRYGÁRKOVÁ Ivona FISCHER Ondřej KOUBKOVÁ Leona ČERNOVSKÁ Markéta TOMÍŠKOVÁ Marcela ROUBEC Jaromír HAVEL Libor HRNČIARIK Michal ZEMANOVÁ Milada ŠATÁNKOVÁ Monika BENEJOVÁ Andrea SIXTOVÁ Dimka KREJČÍ Jana OPÁLKA Petr ČOUPKOVÁ Helena

Conference abstract

Year: 2019, type: Conference abstract
Tyrosine-kinase inhibitors (TKI) in first-line treatment of 470 patients with non-small cell lung cancer (NSCLC) from the Czech Republic

SKŘIČKOVÁ Jana MÁJKOVÁ Petra BAŘINOVÁ M PEŠEK Miloš KOLEK Vítězslav GRYGÁRKOVÁ Ivona FISCHER O KOUBKOVÁ Leona ČERNOVSKÁ M HAVEL Ladislav ROUBEC Jaromír HRNČIARIK Michal ZEMANOVÁ M SIXTOVÁ Dimka BRATOVÁ Monika BENEJOVÁ Andrea OPÁLKA P KREJČÍ J ČOUPKOVÁ Helena TOMÍŠKOVÁ Marcela MERTA Zdeněk

Conference abstract

Year: 2019, type: Conference abstract

2017

Locally advanced breast cancer in elderly patients

HORNOVA Jana BORTLÍČEK Zbyněk MÁJKOVÁ Petra ABRAHAMOVA Jitka KORDIKOVA Drahomira DONATOVA Zuzana KUPEC Martin BOUBLIKOVA Ludmila DVORAK Josef ZAPLETAL Radek BUCHLER Tomas

Article in Periodical

Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic, year: 2017, volume: 161, edition: 2, DOI

2014

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse

POUR Luděk ŠEVČÍKOVÁ Sabina GREŠLIKOVÁ Henrieta KUPSKÁ Renata MÁJKOVÁ Petra ZAHRADOVÁ Lenka SANDECKÁ Viera ADAM Zdeněk KREJČÍ Marta KUGLÍK Petr HÁJEK Roman

Article in Periodical

Haematologica/the hematology journal, year: 2014, volume: 99, edition: 2, DOI

2013

Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib

SMETANA Jan BERÁNKOVÁ Kristina ZAORALOVÁ Romana NĚMEC Pavel GREŠLIKOVÁ Henrieta KUPSKÁ Renata MIKULÁŠOVÁ Aneta FRÖHLICH Jan ŠEVČÍKOVÁ Sabina ZAHRADOVÁ Lenka KREJČÍ Marta SANDECKÁ Viera ALMAŠI Martina KAISAROVÁ Petra MELICHAROVÁ Hana ADAM Zdeněk PENKA Miroslav JARKOVSKÝ Jiří JURCZYSZYN Arthur HÁJEK Roman KUGLÍK Petr

Article in Periodical

Clinical lymphoma, myeloma & leukemia, year: 2013, volume: 13, edition: 2, DOI

2012

Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial

NĚMEC Pavel ZEMANOVA Zuzana KUGLÍK Petr MICHALOVÁ Kyra TAJTLOVA Jana KAISAROVÁ Petra OLTOVA Alexandra FILKOVÁ Hana HOLZEROVÁ Milena BALCÁRKOVÁ Jana JAROSOVA Marie BARABÁŠOVÁ Jana HRUBANOVÁ Martina SPICKA Ivan GREGORA Evzen ADAM Zdeněk ŠČUDLA Vlastimil MAISNAR Vladimír SCHUTZOVA Miroslava HÁJEK Roman

Article in Periodical

Leukemia & Lymphoma, year: 2012, volume: 53, edition: 5, DOI

2011

Association Study of Selected Genetic Polymorphisms and Occurrence of Venous Thromboembolism in Patients With Multiple Myeloma Who Were Treated With Thalidomide

ALMAŠI Martina ŠEVČÍKOVÁ Sabina SLABÝ Ondřej MÁJKOVÁ Petra MAISNAR Vladimír PENKA Miroslav PIKA Tomáš POUR Luděk RADOCHA Jakub ŠČUDLA Vlastimil ŠVÁCHOVÁ Hana HÁJEK Roman

Article in Periodical

Clinical Lymphoma, Myeloma & Leukemia, year: 2011, volume: 11, edition: 5, DOI
Better treatment response is associated with lenalidomide 25 mg once-daily vs. 25 mg every-other-day in relapsed/refractory multiple myeloma

HÁJEK Roman GREGORA Evžen MAISNAR Vladimír MINAŘÍK Jiří PAVLÍČEK P. POUR Luděk RADOCHA J. SCHÜTZOVÁ M. STRAUB J. ŠČUDLA Vlastimil ADAM Zdeněk MÁJKOVÁ Petra

Conference abstract

Year: 2011, type: Conference abstract